B. Braun Medical recalled 46,032 containers of Lactated Ringers Injection USP sold nationwide in the United States. The recall cites the presence of particulate matter in the 1000 mL IV solution. Consumers should stop using the product immediately and contact their healthcare provider or B. Braun for guidance.
Presence of Particulate Matter
Consumers and healthcare providers should stop using this product immediately. Contact B BRAUN MEDICAL INC or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Lactated Ringers Injection USP is a sterile IV solution used for fluid and electrolyte replenishment in clinical settings.
Particulate matter in IV solutions can lead to adverse reactions if administered intravenously. This can include vascular irritation or embolic events depending on the particulates.
This recall is not part of a broader industry pattern.
Affects medical facilities and patients relying on IV therapy; may cause delays in care and require verification of safe inventory.
FDA recall page and manufacturer notices. Serial/lot codes on the IV bag label.
Refund/replacement timelines vary; hospital purchases handled through procurement channels; consumer timelines through hospital or distributor.
Keep recall notices, photos of labels, purchase records, and any correspondence with suppliers.
Product: Lactated Ringers Injection USP, 1000 mL container. Brand: Lactated Ringers. Manufacturer: B. Braun Medical, Inc., Bethlehem, PA 18018-3524 USA. NDC: 0264-7750-07. Quantity: 46,032 containers. Distribution: Nationwide (USA). Lot: J4S807. Expiration: 5/31/2027.
No injuries or incidents have been reported in the provided recall notice.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
B. Braun Medical Inc. recalls 300 extension sets used with Infusomat Space and other pumps. The recall flags potential backflow from piggyback IV containers into primary IV containers and the inability to prime. Hospitals should stop using the device immediately and follow recall instructions.
B. Braun Medical recalled 58,752 Anesthesia IV Sets used with Infusomat Space pumps and other BBMI devices. The recall targets backflow from secondary piggyback IV containers to primary containers and occlusion. Hospitals and clinicians should stop using the device immediately and await manufacturer guidance by recall letter.
B. Braun Medical recalled 554,015 SafeDAY IV administration sets distributed worldwide on Oct 29, 2025. The devices can backflow medication from secondary piggyback containers into primary IV containers and may fail to prime. Hospitals and clinics should stop using the affected sets and follow the manufacturer’s recall instructions.
B. Braun Medical recalls 11,650 extension sets used with Infusomat Space pumps sold worldwide after a backflow and priming defect. The device can allow medication to flow from a piggyback container into the primary line and may not prime properly. Hospitals and patients should stop using the device immediately and follow recall instructions from the manufacturer.
B Braun Medical recalled 18,984 IV administration sets after discovering a potential for backflow of medication from secondary IV containers into primary containers. This defect creates a high risk of medication errors and occlusion. Patients and healthcare providers should stop using these sets immediately and contact B Braun Medical for further instructions.
B Braun Medical recalled 1,200 extension sets used with Infusomat Space large-volume pumps distributed worldwide to hospitals and clinics. The recall cites potential backflow from secondary IV containers into primary containers and an inability to prime (occlusion). Healthcare facilities should stop using the devices immediately and follow the recall instructions issued by the manufacturer.
B Braun Medical Inc recalled 13,600 extension set units used with Infusomat Space and related pumps sold through multiple healthcare distributors worldwide. The recall cites a backflow risk from secondary piggyback containers into primary IV containers and an inability to prime due to occlusion. Healthcare providers and facilities should stop using the device immediately and follow manufacturer-re
BBraun Medical recalled 23,160 IV administration sets distributed worldwide, including the US and Canada, after reports of backflow and occlusion risk. The recall involves catalog number 490487 and UDIs 04046955086856 and 04046955086849. Stop using the product immediately and follow manufacturer instructions for recall procedures.